Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer

. 2016 Dec ; 48 (12) : 1544-1550. [epub] 20161017

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid27749845

Grantová podpora
R01 CA092039 NCI NIH HHS - United States
P30 ES010126 NIEHS NIH HHS - United States
U19 CA203654 NCI NIH HHS - United States
P30 CA047904 NCI NIH HHS - United States
P30 CA016086 NCI NIH HHS - United States
P30 CA023108 NCI NIH HHS - United States
R01 CA090731 NCI NIH HHS - United States
P50 CA097190 NCI NIH HHS - United States
001 World Health Organization - International
MR/N005872/1 Medical Research Council - United Kingdom
U19 CA148127 NCI NIH HHS - United States
RP-PG-0707-10034 Department of Health - United Kingdom

We conducted a genome-wide association study of oral cavity and pharyngeal cancer in 6,034 cases and 6,585 controls from Europe, North America and South America. We detected eight significantly associated loci (P < 5 × 10-8), seven of which are new for these cancer sites. Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5). Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L). Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-HLA-DQB1*0603 (odds ratio (OR) = 0.59, P = 2.7 × 10-9). Stratified analyses on a subgroup of oropharyngeal cases with information available on human papillomavirus (HPV) status indicated that this association was considerably stronger in HPV-positive (OR = 0.23, P = 1.6 × 10-6) than in HPV-negative (OR = 0.75, P = 0.16) cancers.

Cancer Registry of Norway Oslo Norway

Centre for Oral Health Research Newcastle University Newcastle UK

Clinical Translational Science Institute University of California at San Francisco San Francisco California USA

Croatian National Institute of Public Health Zagreb Croatia

Deparment of Molecular Medicine University of Padova Padova Italy

Departamento de Medicina Preventiva Faculdade de Medicina da Universidade de São Paulo São Paulo Brazil

Department for Determinants of Chronic Diseases Bilthoven the Netherlands

Department of Biomedical Data Sciences Geisel School of Medicine at Dartmouth Lebanon New Hampshire USA

Department of Cancer Epidemiology and Prevention Institute of Carcinogenesis N N Blokhin Russian Cancer Research Centre of the Russian Ministry of Health Moscow Russian Federation

Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Lodz Poland

Department of Epidemiology and Biostatistics School of Public Health Imperial College London London UK

Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Department of Epidemiology Graduate School of Public Health University of Pittsburgh Pittsburgh Pennsylvania USA

Department of Gastroenterology Radboud University Nijmegen Medical Center Nijmegen the Netherlands

Department of Head and Neck Surgery Heliópolis Hospital São Paulo Brazil

Department of Hygiene Epidemiology and Medical Statistics School of Medicine National and Kapodistrian University of Athens Athens Greece

Department of Medical Sciences University of Turin Turin Italy

Department of Molecular Biology School of Medicine of São José do Rio Preto São José do Rio Preto Brazil

Department of Otolaryngology Head and Neck Surgery University of California at San Francisco San Francisco California USA

Department of Otolaryngology Head and Neck Surgery University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Department of Otorhinolaryngology Head and Neck Surgery Maastricht University Medical Center Maastricht the Netherlands

Department of Social and Preventive Medicine Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

Department of Stomatology School of Dentistry University of São Paulo São Paulo Brazil

Epidemiology International Center for Research A C Camargo Cancer Center Sao Paulo Brazil

Faculdade de Saúde Pública Universidade de São Paulo São Paulo Brazil

German Institute of Human Nutrition in Potsdam Rehbruecke Nuthetal Germany

Institut Català d'Oncologia IDIBELL CIBERESP l'Hospitalet de Llobregat Barcelona Spain

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Otorhinolaryngology Università Cattolica del Sacro Cuore Fondazione Policlinico 'Agostino Gemelli' Rome Italy

Instituto de Oncología 'Angel H Roffo' Universidad de Buenos Aires Buenos Aires Argentina

International Agency for Research on Cancer Lyon France

Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany

Lunenfeld Tanenbaum Research Institute Mount Sinai Hospital Toronto Ontario Canada

Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology Warsaw Poland

National Institute for Health Research Biomedical Research Unit in Nutrition Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol Bristol UK

National Institute of Public Health Bucharest Romania

NHS National Services Scotland Edinburgh UK

Princess Margaret Cancer Centre Toronto Ontario Canada

Programa de Pós Graduacão em Epidemiologia Universidade Federal de Pelotas Pelotas Brazil

Regional Authority of Public Health Banská Bystrica Slovakia

School of Medicine Dentistry and Nursing University of Glasgow Glasgow UK

School of Medicine Medical Sciences and Nutrition University of Aberdeen Aberdeen UK

School of Oral and Dental Sciences University of Bristol Bristol UK

Section of Hygiene Institute of Public Health Università Cattolica del Sacro Cuore Fondazione Policlinico 'Agostino Gemelli' Rome Italy

Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York USA

Trinity College School of Dental Science Dublin Ireland

UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina USA

Unit of Cancer Epidemiology CRO Aviano National Cancer Institute Aviano Italy

Unit of Nutrition and Cancer Cancer Epidemiology Research Program Institut Català d'Oncologia IDIBELL l'Hospitalet de Llobregat Barcelona Spain

University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania USA

Zobrazit více v PubMed

Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235–42. PubMed PMC

Chaturvedi AK, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology. 2011;29:4294–4301. PubMed PMC

Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–75. PubMed

Ribeiro KB, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011;40:489–502. PubMed

Lopez RV, et al. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control. 2014;25:461–71. PubMed

Hashibe M, et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nature genetics. 2008;40:707–709. PubMed

McKay JD, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS genetics. 2011;7:e1001333. PubMed PMC

McCarthy S, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279–1283. PubMed PMC

de Bakker PI, et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet. 2008;17:R122–8. PubMed PMC

Hashibe M, et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 2006;15:696–703. PubMed

Chang JS, Straif K, Guha N. The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. Mutagenesis. 2012;27:275–86. PubMed

Ramasamy A, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17:1418–28. PubMed PMC

Carre C, Shiekhattar R. Human GTPases associate with RNA polymerase II to mediate its nuclear import. Mol Cell Biol. 2011;31:3953–62. PubMed PMC

GTEx-Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–60. PubMed PMC

McKay JD, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40:1404–6. PubMed PMC

Wang Y, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008;40:1407–9. PubMed PMC

Rafnar T, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41:221–7. PubMed PMC

Stacey SN, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet. 2009;41:909–14. PubMed PMC

Yin J, et al. TERT-CLPTM1L Rs401681 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. PLoS One. 2014;9:e100667. PubMed PMC

Petersen GM, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224–8. PubMed PMC

Bei JX, et al. A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. Cancer Epidemiol Biomarkers Prev. 2016;25:188–92. PubMed PMC

Law MH, et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet. 2015;47:987–95. PubMed PMC

Shete S, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899–904. PubMed PMC

Turnbull C, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42:504–7. PubMed PMC

Timofeeva MN, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012;21:4980–95. PubMed PMC

Bei JX, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010;42:599–603. PubMed

Wu C, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet. 2014;46:1001–6. PubMed PMC

The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–82. PubMed PMC

Barak T, et al. Recessive LAMC3 mutations cause malformations of occipital cortical development. Nat Genet. 2011;43:590–4. PubMed PMC

Chen D, et al. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst. 2013;105:624–33. PubMed

Bouvard V, et al. A review of human carcinogens—Part B: biological agents. The lancet oncology. 2009;10:321–322. PubMed

Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology. 2012;1:908–916. PubMed PMC

Consortium launches genotyping effort. Cancer Discov. 2013;3:1321–2. PubMed

Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75. PubMed PMC

Price AL, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–9. PubMed

Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 2003;164:1567–87. PubMed PMC

Das S, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016 doi: 10.1038/ng.3656. PubMed DOI PMC

Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2012;9:179–81. PubMed

Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinformatics. 2015;31:782–4. PubMed PMC

Jia X, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One. 2013;8:e64683. PubMed PMC

Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–4. PubMed PMC

Turner SD. qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. bioRxiv. 2014

Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal of Statistical Software. 2010;36:48.

Pruim RJ, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7. PubMed PMC

Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555–7. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...